100 related articles for article (PubMed ID: 2972250)
1. Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis.
Rose LM; Ginsberg AH; Rothstein TL; Ledbetter JA; Clark EA
Ann Neurol; 1988 Aug; 24(2):192-9. PubMed ID: 2972250
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.
Hauser SL; Reinherz EL; Hoban CJ; Schlossman SF; Weiner HL
Ann Neurol; 1983 Apr; 13(4):418-25. PubMed ID: 6220668
[TBL] [Abstract][Full Text] [Related]
3. T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases.
Bach MA; Martin C; Cesaro P; Eizenbaum JF; Degos JD
J Neuroimmunol; 1985; 7(5-6):331-43. PubMed ID: 3871792
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysis.
Bongioanni P; Fioretti C; Vanacore R; Bianchi F; Lombardo F; Ambrogi F; Meucci G
J Neurol Sci; 1996 Jul; 139(1):71-7. PubMed ID: 8836975
[TBL] [Abstract][Full Text] [Related]
5. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
Kastrukoff LF; Paty DW
Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
[TBL] [Abstract][Full Text] [Related]
6. [Memory T cell subsets in peripheral blood of patients with multiple sclerosis].
Liu GZ; Gao XG
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2750-2. PubMed ID: 18167264
[TBL] [Abstract][Full Text] [Related]
7. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
8. Fluctuations in T helper subpopulations in relapsing-remitting multiple sclerosis.
Corrigan E; Hutchinson M; Feighery C
Acta Neurol Scand; 1990 May; 81(5):443-7. PubMed ID: 2142848
[TBL] [Abstract][Full Text] [Related]
9. Study of serial lymphocyte subsets in multiple sclerosis: their possible role in the evaluation of disease progression.
Cazzullo CL; Zaffaroni M; Caputo D; Ghezzi A
Riv Neurol; 1987; 57(1):24-6. PubMed ID: 2957783
[TBL] [Abstract][Full Text] [Related]
10. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
[TBL] [Abstract][Full Text] [Related]
12. [Changes in lymphocyte subsets s and treatment with beta interferon in active multiple sclerosis].
Gata JM; García-Moreno JM; Dinca L; Sánchez-Margalet V; Navarro G; Izquierdo G
Rev Neurol; 1998 Dec; 27(160):939-42. PubMed ID: 9951008
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
[TBL] [Abstract][Full Text] [Related]
14. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
[TBL] [Abstract][Full Text] [Related]
15. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral blood lymphocyte subsets in acute relapsing multiple sclerosis].
Yang YC
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):146-9, 189. PubMed ID: 2143976
[TBL] [Abstract][Full Text] [Related]
17. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
de Andrés C; Aristimuño C; Bartolomé M; de Las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2009 Jul; 212(1-2):112-20. PubMed ID: 19446889
[TBL] [Abstract][Full Text] [Related]
18. Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity.
Hauser SL; Bresnan MJ; Reinherz EL; Weiner HL
Ann Neurol; 1982 May; 11(5):463-8. PubMed ID: 6213188
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
